a 15

a15:0-i15:0 PE is a dia-cyl phosphatidylethanolamine with two branched chains. It functions as an atypical TLR2-TLR1 heterodimer agonist and is immunogenic. This compound activates T cell and dendritic cell (DC) signaling, exhibiting anti-inflammatory properties. Additionally, a15:0-i15:0 PE induces the production of TNFα and IL-6. It is a major component of the A. muciniphila lipid membrane, constituting approximately 50%.

16:0-a15:0 PC is a type of branched-chain lipid.

a15:0-i15:0 PG sodium is a branched lipid.

a15:0-i15:0 PC is a branched lipid.

PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) is a matrix material for cancer drug delivery, characterized by a lactic acid to glycolic acid ratio of 15:1. This compound enhances drug bioavailability, efficacy, solubility, drug encapsulation efficiency, and sustained release while minimizing adverse toxicity.

Pgf2alpha 15-methyl ether is primarily used for the prevention of postpartum hemorrhage.

15-Stachen-19-ol; Erythroxylol A; 15-Beyeren-19-ol is a useful organic compound for research related to life sciences. The catalog number is T125414 and the CAS number is 20107-90-8.

tCFA15, a trimethyl cyclohexenonic long-chain fatty alcohol with a 15-carbon atom side chain, may regulate Notch signaling and promote neuronal differentiation.

FA-15 is a phenolic antioxidant used to stabilize reactive fuels.

SA-15-P inhibits the interactions of LAG-3/MHCII and LAG-3/FGL1 with respective IC50 values of 4.21 and 6.52 μM. The LAG-3/MHCII interaction is a target in immunotherapy.

Diaza-15-crown-5, a crown ether compound, can extend the lifespan of the M intermediate in BR membranes. By altering the surface charge of the BR membrane, Diaza-15-crown-5 affects the interactions between BR molecules and enhances the overall stability of the membrane, allowing the M state to be sustained longer.

WYFA-15 is an inhibitor of sphingomyelin synthase 1 (SMS1) that has been shown to protect mice from lethal SFTSV infection and reduce the replication and pathogenicity of SARS-CoV-2. WYFA-15 is applicable for antiviral research.

Ena15 is an ALKBH5 inhibitor that enhances the demethylase activity of FTO. It can increase m6A RNA levels and stabilize FOXM1 mRNA. Additionally, Ena15 inhibits the growth activity of glioblastoma multiforme.

HA15-Biotin is a chemically synthesized compound comprising HA15 which is connected to biotin through the amide group. It demonstrates comparable activity to HA15 and holds potential for use in proteomic analysis.

ISRIB-A15 (ISR-IN-2) is an potent inhibitor of the integrated stress response with an EC50 of 0.8 nM.

HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.

Urea-15N2 is the 15N labeled form of Urea. Urea serves as a potent protein denaturant, operating through both direct and indirect mechanisms. It acts as an effective emollient and keratolytic agent and is used as a diuretic. Blood urea nitrogen (BUN) has been employed to assess kidney function. Additionally, it is widely used as a nitrogen source in fertilizers and is a significant raw material in the chemical industry.

ent-Labda-8(17),13E-diene-3beta,15,18-triol is a natural product for research related to life sciences. The catalog number is TN3960 and the CAS number is 90851-50-6.

Alkynyl Palmitic Acid is an alkyl chain-based PROTAC linker that can be used in PROTAC synthesis.

STC-15 is an orally active and potent METTL3 inhibitor with anticancer activity that inhibits cancer growth and induces anticancer immunity.

DHODH-IN-15 is the hydroxyfuran analogue of A771726. DHODH-IN-15 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 11 μM for rat liver DHODH. DHODH-IN-15 can be used for rheumatoid arthritis.

STK-15 is a candidate for use as an inhibitor of fatty acid binding protein 5 (FABP5).

B-Raf IN 15 is a BRAF inhibitor that inhibits BRAFWT and BRAFV600E and can be used in the study of melanoma and cancer, and can be optimized for use as a more effective BRA F inhibitor.

Rec 15/2615 dihydrochloride is an antagonist of α1B-adrenergic receptor.